Literature DB >> 10197861

Increased incidence of testicular cancer in active duty members of the Department of Defense.

I M Thompson1, S Optenberg, R Byers, M Dove.   

Abstract

OBJECTIVES: Multiple reports have noted an increase in testicular cancer incidence in virtually all world populations. We sought to determine whether an increase in testicular cancer incidence has occurred in active duty members of the Department of Defense (DOD).
METHODS: The total number of tumors accessioned at all DOD tumor registries, encompassing virtually all tumors diagnosed in active duty personnel, was obtained from the centralized DOD tumor registry. The number of men on active duty in the DOD was obtained from the Defense Manpower Data Center.
RESULTS: The rate of testicular cancer increased from 8.62/100,000 active duty men in 1988 to 15.38/100,000 in 1996.
CONCLUSIONS: These data corroborate observations from multiple other populations that the incidence of testicular cancer is increasing. The explanation for this observation is unknown.

Entities:  

Mesh:

Year:  1999        PMID: 10197861     DOI: 10.1016/s0090-4295(98)00609-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.

Authors:  Lindsey Enewold; Jing Zhou; Susan S Devesa; Ralph L Erickson; Kangmin Zhu; Katherine A McGlynn
Journal:  Mil Med       Date:  2011-10       Impact factor: 1.437

2.  Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Authors:  Lindsey R Enewold; Jing Zhou; Susan S Devesa; Amy Berrington de Gonzalez; William F Anderson; Shelia H Zahm; Alexander Stojadinovic; George E Peoples; Aizenhawar J Marrogi; John F Potter; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-13       Impact factor: 4.254

3.  Cancer incidence in the U.S. military population: comparison with rates from the SEER program.

Authors:  Kangmin Zhu; Susan S Devesa; Hongyu Wu; Shelia Hoar Zahm; Ismail Jatoi; William F Anderson; George E Peoples; Larry G Maxwell; Elder Granger; John F Potter; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.